CNTB connectbiopharm.com: Forvard P/S multiplikatori
Tijorat mahsulotlari mavjud bo'lmagan holda doimiy R&D xarajatlari moliyaviy defitsitni yuzaga keltirmoqda, bu esa taxminiy forward P/S ko'rsatkichini kutishlarni tahlil qilish uchun asosiy vositaga aylantiradi. 14.10 qiymati bozor baholashining bazaviy ko'rsatkichi vazifasini o'taydi. Astma davolashga bo'lgan barqaror talab makroiqtisodiy ta'sirni yumshatadi, aksiyalar opsionlari orqali yetakchi immunologlarni saqlab qolish esa Connect Biopharma (CNTB) o'zining ilmiy salohiyatini saqlab qolishini ta'minlaydi.
connectbiopharm.com - tahliliy kesimlar va asosiy koʻrsatkichlar (CNTB)
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Qarzning xususiy kapitalga nisbati Connect Biopharma|CNTB - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning kapitalga nisbati Connect Biopharma Holdings Limited|CNTB - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar CNTB|CNTB - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli majburiyatlari Connect Biopharma|Tezkor likvidlik ko‘rsatkichi connectbiopharm.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CNTB - Yakuniy foyda|Prognoz qilingan kelajakdagi foyda Connect Biopharma|CNTB - Narxning foydaga nisbati|Forvard P/E multiplikatori Connect Biopharma Holdings Limited|CNTB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati CNTB|CNTB - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Connect Biopharma|CNTB - So'nggi 12 oy davomida bitta aksiya uchun foyda|Choraklik EPS foyda o'sishi connectbiopharm.com|CNTB - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Connect Biopharma
- tushum va sotuvlar tafsilotlari:
Kompaniyaning dastlabki tahlili:Connect Pharma CNTB
Connect Biopharma daromadlari autoimmun yallig'lanish va atopik dermatit uchun innovatsion terapiyalarning bozorda muvaffaqiyatli ishga tushirilishiga bog'liq. Kompaniyaning forward P/S grafigini tahlil qilish orqali investor joriy kapitalizatsiyani prognoz qilingan daromadga nisbatan baholaydi, bu esa ularga bozor shovqinlarini filtrlash va bozor dori vositalarining kelgusidagi tijoratlashtirilishini allaqachon hisobga olganmi yoki aktiv haddan tashqari qimmat baholanganmi, shuni aniqlash imkonini beradi.
Connect Biopharma (CNTB) raqobatchilari
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA Corp (ADMA) - Forvard narx/daromad multiplikatori|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati immunovant.com (IMVT)|Narxning prognoz qilingan daromadga nisbati Kiniksa|Kapitalizatsiyaning prognoz qilingan daromadga nisbati GRFS (Grifols SA)|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Celldex Corp - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|biocryst.com (BCRX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Vera Therapeutics - Forvard P/S multiplikatori|Dianthus Therapeutics Inc (DNTH) - Forvard narx/daromad multiplikatori|PHVS (Pharvaris Corp) - Forvard narx/daromad multiplikatori|ABCL: Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori TRML|PGEN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PHAR|Narxning prognoz qilingan daromadga nisbati NKTR (Nektar Therapeutics Inc)|Forvard P/S multiplikatori UPB (Upstream Bio Corp)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Zenas Corp (ZBIO)|IMNM - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati gossamerbio.com|KalVista Pharmaceuticals, Inc. (KALV) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati SEPN (Septerna, Inc.)|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|SVRA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori RIGL|Forvard P/S multiplikatori anaptysbio.com (ANAB)|Narxning prognoz qilingan daromadga nisbati Astria Therapeutics, Inc. ATXS|Sotuvga nisbatan forvard narx ENGN|RAPT - Narxning prognoz qilingan daromadga nisbati|Aerovate Therapeutics Inc (JBIO) - Forvard narx/daromad multiplikatori|ACRS: Forvard P/S multiplikatori|kyvernatx.com (KYTX) - Forvard P/S multiplikatori|TLSA (Tiziana Life Sciences Ltd) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cabaletta Bio Inc. (CABA)|Narxning prognoz qilingan daromadga nisbati Ventyx Bio (VTYX)|Theratechnologies, Inc - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Avalo Therapeutics, Inc - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ELDN (eledon.com)|Agenus Inc. - Forvard P/S multiplikatori|CLYM: Narxning prognoz qilingan daromadga nisbati|Zura Bio Limited (ZURA) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati ATYR (aTyr Pharmaceuticals)|ADAG (Adagene Inc) - Forvard P/S multiplikatori|IMA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori STTK|Forvard P/S multiplikatori equilliumbio.com (EQ)|Narxning prognoz qilingan daromadga nisbati Immunic IMUX|Sotuvga nisbatan forvard narx ATRA|IFRX - Narxning prognoz qilingan daromadga nisbati|x4pharma.com (XFOR) - Forvard narx/daromad multiplikatori|ACET: Forvard P/S multiplikatori|Celularity (CELU) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori INMB|BRNS: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori KZR|Kapitalizatsiyaning kutilayotgan sotuvga nisbati sabbiotherapeutics.com|Narxning prognoz qilingan daromadga nisbati Akari Therapeutics Plc AKTX|ENLV - Forvard narx/daromad multiplikatori|QTTB - Narxning prognoz qilingan daromadga nisbati|GeoVax Corp (GOVX) - Forvard narx/daromad multiplikatori|EDSA (Edesa Biotech, Inc.) - Forvard narx/daromad multiplikatori|ibioinc.com (IBIO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Carisma Therapeutics Inc|Kapitalizatsiyaning prognoz qilingan daromadga nisbati XTLB (XTL Biopharmaceuticals Ltd)|Forvard P/S multiplikatori BOLT|HCWB - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|AIM - Forvard narx/daromad multiplikatori|ADTX - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati GRI Bio Inc|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HIND|Narxning prognoz qilingan daromadga nisbati Revelation Biosciences|Kapitalizatsiyaning prognoz qilingan daromadga nisbati INDP (indaptusrx.com)|Forvard P/S multiplikatori SCNI|CALI - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori AFMD (Affimed N.V.)|ALLK - Forvard narx/daromad multiplikatori|HOOK: Forvard narx/daromad multiplikatori|IGM Biosciences, Inc. - Narxning kutilayotgan daromadga nisbati|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Inc - Sotuvga nisbatan forvard narx|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati THRD
